Clinical Trial Update: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating maximal usage pharmacokinetics and safety of ARQ-151 in children with plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• ARQ-151

Snippet

Sponsor: Arcutis Biotherapeutics, Inc. | Conditions: Psoriasis, Plaque Psoriasis | Phase 2 | Status: COMPLETED